特定恶性细胞群单细胞去卷积作为低危透明细胞肾细胞癌患者的不良预后生物标志物
本研究对5例未治疗透明细胞肾细胞癌(ccRCC)患者肿瘤样本行单细胞RNA测序,分析54 812个细胞并鉴定35个细胞亚群,揭示肿瘤内表达异质性;基于一例高度异质性样本的恶性细胞转录组特征设计去卷积策略,对310例低危ccRCC患者进行风险分层。
要点
- 对5例未治疗ccRCC患者肿瘤样本行单细胞RNA测序,分析54 812个细胞并鉴定35个细胞亚群。
- 表达异质性分析显示每例肿瘤含有不同程度的克隆多样性。
- 基于恶性细胞转录组特征的去卷积策略可对310例低危ccRCC患者进行风险分层。
核心结论
- 研究描述了ccRCC的肿瘤内表达异质性,并据此建立基于细胞群体的显著预后特征以更好区分ccRCC患者。
- 该方法有潜力改善临床低危患者的分层及其治疗管理。
研究设计与样本
- 对5例未治疗ccRCC患者(pT1a至pT3b)肿瘤样本行单细胞RNA测序,数据与已发表的配对正常和ccRCC样本数据集互补。
- 干预为未治疗ccRCC患者的根治性或部分性肾切除术。
- 采用流式细胞术测定活力和细胞类型比例,行功能分析并推断肿瘤进展轨迹,在外部队列应用去卷积方法并以恶性细胞簇的流行率估计Kaplan-Meier生存曲线。
主要发现
- 分析54 812个细胞并鉴定35个细胞亚群。
- 表达异质性分析显示每例肿瘤含有不同程度的克隆多样性。
- 以一例高度异质性样本的恶性细胞转录组特征设计去卷积策略,对310例低危ccRCC患者进行风险分层。
临床怎么用
- 原文结论指出该方法有潜力改善临床低危ccRCC患者的分层及其治疗管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intratumor heterogeneity (ITH) is a key feature in clear cell renal cell carcinomas (ccRCCs) that impacts outcomes such as aggressiveness, response to treatments, or recurrence. In particular, it may explain tumor relapse after surgery in clinically low-risk patients who did not benefit from adjuvant therapy. Recently, single-cell RNA sequencing (scRNA-seq) has emerged as a powerful tool to unravel expression ITH (eITH) and might enable better assessment of clinical outcomes in ccRCC. OBJECTIVE: To explore eITH in ccRCC with a focus on malignant cells (MCs) and assess its relevance to improve prognosis for low-risk patients. DESIGN, SETTING, AND PARTICIPANTS: We performed scRNA-seq on tumor samples from five untreated ccRCC patients ranging from pT1a to pT3b. Data were complemented with a published dataset composed of pairs of matched normal and ccRCC samples. INTERVENTION: Radical or partial nephrectomy on untreated ccRCC patients. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Viability and cell type proportions were determined by flow cytometry. Following scRNA-seq, a functional analysis was performed and tumor progression trajectories were inferred. A deconvolution approach was applied on an external cohort, and Kaplan-Meier survival curves were estimated with respect to the prevalence of malignant clusters. RESULTS AND LIMITATIONS: We analyzed 54 812 cells and identified 35 cell subpopulations. The eITH analysis revealed that each tumor contained various degrees of clonal diversity. The transcriptomic signatures of MCs in one particularly heterogeneous sample were used to design a deconvolution-based strategy that allowed the risk stratification of 310 low-risk ccRCC patients. CONCLUSIONS: We described eITH in ccRCCs, and used this information to establish significant cell population-based prognostic signatures and better discriminate ccRCC patients. This approach has the potential to improve the stratification of clinically low-risk patients and their therapeutic management. PATIENT SUMMARY: We sequenced the RNA content of individual cell subpopulations composed of clear cell renal cell carcinomas and identified specific malignant cells the genetic information of which can be used to predict tumor progression.
引用
- Saout JR, Lecuyer G, Léonard S, et al. Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma Patients. Eur Urol. 2023. PMID: 36801089. doi:10.1016/j.eururo.2023.02.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。